terfenadine has been researched along with Hives in 121 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "H1-antihistamines are the first-line treatment of chronic idiopathic urticaria (CIU), but CIU is occasionally refractory to the conventional treatment doses." | 9.17 | Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. ( Kabashima, K; Miyachi, Y; Nakahigashi, K; Tanizaki, H, 2013) |
| "The present study examined the impact of once-daily fexofenadine hydrochloride (HCl) 180 mg on health-related quality of life (HRQL) in subjects with chronic idiopathic urticaria (CIU)." | 9.12 | The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. ( Harding, G; Leahy, MJ; Meeves, S; Shikiar, R; Spector, SL, 2007) |
| "The effect of 60 mg twice-daily fexofenadine HCl on health-related quality of life and productivity at work, in the classroom, and during daily activities in patients with moderate to severe chronic idiopathic urticaria symptoms was studied in two identical, 4-week, placebo-controlled, multicenter clinical trials." | 9.09 | Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. ( Finn, AF; Schoenwetter, WF; Thompson, AK, 2000) |
| "This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria." | 9.09 | Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000) |
| "In this 4-week, multicenter, placebo-controlled study, 439 patients with moderate to severe pruritus and urticaria received 1 of 4 oral doses of fexofenadine HCl (20, 60, 120, or 240 mg twice a day) or placebo." | 9.09 | A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. ( Finn, AF; Fretwell, R; Kaplan, AP; Long, J; Qu, R, 1999) |
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 9.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 9.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 9.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 9.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "The objective of these three double-blind multi-centre studies was to determine whether terfenadine 120 mg once daily has similar efficacy and tolerability as the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 9.06 | Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily. ( , 1989) |
| "Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria." | 9.06 | Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. ( Cainelli, T; Mosca, M; Seidenari, S; Valsecchi, R, 1986) |
| "45 patients with chronic urticaria were randomized to double blind therapy with terfenadine an H1-antihistamine or ranitidine, an H2-antihistamine, or a combination of both drugs." | 9.06 | Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. ( Bödeker, RH; Paul, E, 1986) |
| "The objective of this double-blind study, which is part of a multicenter study, was to determine whether terfenadine (120 mg once daily) has similar efficacy and tolerability to the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 9.06 | Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. ( Köhler, ME; Paul, E; Reinel, D; Ulrich, R, 1989) |
| "Patients (n = 56) with a diagnosis of chronic idiopathic urticaria were assessed in a fully randomized, double-blind, crossover study to investigate the efficacy of acrivastine at two doses (8 and 4 mg) versus 60 mg terfenadine and placebo administered three times daily." | 9.06 | A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. ( Blog, FB; den Boer, MS; Gibson, JR; Harvey, SG; Jansen, FC; Kuneman, JJ; Starink, TM; van Joost, T; Westerhof, W, 1989) |
| "Forty patients with chronic urticaria were treated with terfenadine or astemizole in a randomized double-blind study." | 9.06 | Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. ( Bödeker, RH; Paul, E, 1989) |
| "The effects of brompheniramine maleate (12 mg twice daily in sustained release form) and terfenadine (60 mg twice daily) on the symptoms and well-being of 16 adults with urticaria with or without dermographism were assessed by symptom questionnaire." | 9.06 | Terfenadine and brompheniramine maleate in urticaria and dermographism. ( Baker, R; Ormerod, AD; Watt, J; White, MI, 1986) |
| "Terfenadine, a new specific and peripherally acting antihistamine, was compared with clemastine and placebo in a prospective, randomized, double-blind, double-dummy, crossover study of the treatment of chronic urticaria." | 9.06 | Terfenadine in chronic urticaria: a comparison with clemastine and placebo. ( Fredriksson, T; Hersle, K; Hjorth, N; Mobacken, H; Persson, T; Salde, L; Salo, O; Schmidt, H; Thomsen, K, 1986) |
| "Results of a double-blind, randomized, placebo-controlled, parallel study in 37 patients indicate that terfenadine, 60 mg bid, is significantly more effective than placebo and as effective as hydroxyzine, 25 mg qid, in the treatment of chronic idiopathic urticaria without causing the somnolence that was associated with the use of hydroxyzine." | 9.06 | Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. ( Ball, R; Boggs, PB; Ellis, CN; Grossman, J; Gupta, AK; Shulan, D; Washburne, WF, 1989) |
| "The efficacy of terfenadine, a nonsedating H1 antihistamine, in the management of chronic idiopathic urticaria was compared with chlorpheniramine and placebo in a parallel multicenter trial." | 9.06 | Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. ( Bernstein, DI; Buckley, CE; Chu, T; Fox, RW; Grant, JA; Rocklin, RE; Schoenwetter, WF; Spector, SL; Stafford, CT; Stroh, JE, 1988) |
| "The use of the nonsedating antihistamine terfenadine (60 mg twice daily) in the treatment of chronic idiopathic urticaria and contact urticaria associated with atopic dermatitis was assessed." | 9.06 | Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. ( Hjorth, N, 1988) |
| " In a double blind crossover study of twenty-four patients with chronic idiopathic urticaria, we have found terfenadine to be a non-sedative and highly effective drug." | 9.05 | Treatment of chronic idiopathic urticaria with terfenadine. ( Cerio, R; Lessof, MH, 1984) |
| "Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial." | 9.05 | Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study. ( Ferguson, J; Kenicer, KJ; MacDonald, KJ, 1985) |
| "40 patients suffering from chronic urticaria were randomly treated with either Terfenadine or Astemizole." | 9.05 | [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients]. ( Bödeker, RH; Paul, E, 1985) |
| "A 40-year-old male medical student presented with urticarial vasculitis secondary to occupational formaldehyde exposure." | 7.74 | Formaldehyde-induced urticarial vasculitis. ( Marshman, G; Pellizzari, M, 2007) |
| "fexofenadine is clinically effective in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria for which it is a suitable option for first-line therapy." | 7.70 | Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. ( Jarvis, B; Simpson, K, 2000) |
| " The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new dihydropyridine anti-calcium derivative for physical stimulus-induced urticaria, in comparison with a standard H1-antihistamine therapy." | 7.68 | Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria. ( Altomare, G; Bigardi, A; Finzi, AF; Fumagalli, M; Pigatto, PD, 1990) |
| "To investigate the mechanisms of non-immunologic contact urticaria (NICU), the effect of 120 mg of terfenadine (H1-antagonist) on contact reactions to methyl nicotinate, diethyl fumarate, benzoic acid, cinnamic acid, cinnamic aldehyde and dimethyl sulfoxide was studied in 20 subjects." | 7.67 | Terfenadine does not inhibit non-immunologic contact urticaria. ( Lahti, A, 1987) |
| "Treatment with the H1 receptor antagonist terfenadine increased significantly the dose of radiation required for weal and flare formation in 5 patients with idiopathic solar urticaria." | 7.67 | Treatment of solar urticaria with terfenadine. ( Diffey, BL; Farr, PM, 1988) |
| "To evaluate the efficacy and safety of once-daily dosing of fexofenadine hydrochloride, 180 mg, on CIU." | 6.71 | Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. ( Georges, G; Kaplan, AP; Liao, Y; Meeves, S; Spector, SL; Varghese, ST, 2005) |
| "Fexofenadine 180 mg is a new antihistamine that is effective in the treatment of chronic urticaria and that has a profile of side effects similar to placebo." | 6.70 | [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. ( Bircher, A; Degonda, M; Helbling, A; Pichler, WJ, 2002) |
| " Adverse events occurred in 20 cases (18." | 6.70 | Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria. ( Aunhachoke, K; Charuwichitratana, S; Gherunpong, N; Gritiyarangsan, P; Janjumratsang, P; Jiamton, S; Korkij, W; Krisadapong, J; Kullavanijaya, P; Kulthanan, K; Kuntiranont, M; Sitakalin, C, 2001) |
| "Terfenadine was significantly more effective than placebo at day 7 and endpoint (last valid visit)." | 6.67 | Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. ( Belaich, S; Bruttmann, G; DeGreef, H; Lachapelle, JM; Paul, E; Pedrali, P; Tennstedt, D, 1990) |
| " At the dosage used, cetirizine therapy appears to be no more effective than terfenadine." | 6.67 | A comparison of cetirizine and terfenadine in the management of solar urticaria. ( Bilsland, D; Ferguson, J, 1991) |
| "Total 100 patients of chronic idiopathic urticaria aged 18 years and above with exclusion and inclusion criteria were selected." | 5.56 | Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria. ( Akhter, F; Jahan, H; Nandi, AK, 2020) |
| " Fexofenadine given in the conventional dosage can prevent recurrences and represents a successful treatment measure when dealing with this peculiar form of solar urticaria." | 5.31 | Fixed solar urticaria to visible light successfully treated with fexofenadine. ( Bazex, J; Journé, F; Loche, E; Marguery, MC; Schwarze, HP, 2001) |
| "Terfenadine is a widely used antihistamine." | 5.29 | Torsade de pointes induced by terfenadine in a patient with long QT syndrome. ( Kim, SS; Koh, KK; Rim, MS; Yoon, J, 1994) |
| "Solar urticaria is a rare photodermatosis, but it is extremely incapacitating and therapy is usually ineffective." | 5.28 | [Treatment of solar urticaria: advantage of terfenadine]. ( Civatte, J; Jeanmougin, M; Manciet, JR; Moulin, JP, 1989) |
| "H1-antihistamines are the first-line treatment of chronic idiopathic urticaria (CIU), but CIU is occasionally refractory to the conventional treatment doses." | 5.17 | Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations. ( Kabashima, K; Miyachi, Y; Nakahigashi, K; Tanizaki, H, 2013) |
| "Nonsedating antihistamines (nsAHs) are recommended as first-line therapeutics for the treatment of mast cell-driven disorders, including allergic rhinitis and urticaria." | 5.14 | Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines. ( dos Santos, RV; Lima, HC; Magerl, M; Mlynek, A, 2009) |
| "The present study examined the impact of once-daily fexofenadine hydrochloride (HCl) 180 mg on health-related quality of life (HRQL) in subjects with chronic idiopathic urticaria (CIU)." | 5.12 | The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria. ( Harding, G; Leahy, MJ; Meeves, S; Shikiar, R; Spector, SL, 2007) |
| "Levocetirizine is the active enantiomer of cetirizine, a potent drug with little metabolism widely used for allergic rhinitis and urticaria." | 5.10 | A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. ( DeVos, C; Grant, JA; Moulaert, B; Riethuisen, JM, 2002) |
| "In this 4-week, multicenter, placebo-controlled study, 439 patients with moderate to severe pruritus and urticaria received 1 of 4 oral doses of fexofenadine HCl (20, 60, 120, or 240 mg twice a day) or placebo." | 5.09 | A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. ( Finn, AF; Fretwell, R; Kaplan, AP; Long, J; Qu, R, 1999) |
| "This dose-finding study assessed the safety and efficacy of fexofenadine in chronic idiopathic urticaria." | 5.09 | Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. ( Mason, J; Nelson, HS; Reynolds, R, 2000) |
| "The effect of 60 mg twice-daily fexofenadine HCl on health-related quality of life and productivity at work, in the classroom, and during daily activities in patients with moderate to severe chronic idiopathic urticaria symptoms was studied in two identical, 4-week, placebo-controlled, multicenter clinical trials." | 5.09 | Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. ( Finn, AF; Schoenwetter, WF; Thompson, AK, 2000) |
| "Pretreatment with fexofenadine during venom immunotherapy reduces local allergic reactions and generalized symptoms of the urticaria and angioedema type." | 5.09 | Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. ( Hari, Y; Müller, U; Reimers, A, 2000) |
| "Ebastine is a new second generation histamine H1 receptor antagonist that has shown clinical efficacy in the treatment of seasonal and perennial allergic rhinitis and chronic urticaria after once-daily administration." | 5.08 | Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults. ( Kalis, B, 1996) |
| "Clinical trials of a new histamine H1-blocker of the III generation zyrtec (cetirizine) manufactured in Belgium (UCB) demonstrated its high efficacy in pollenosis and chronic idiopathic urticaria." | 5.07 | [The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis]. ( Androsov, VN; Belostotskaia, OI; Il'ina, NI, 1994) |
| "Our randomised study in parallel groups, double-blind double placebo, has compared the efficacy, onset of action and safety of terfenadine and cetirizine in chronic idiopathic urticaria." | 5.07 | [Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria]. ( Bloom, M; Danglas, P; Hantzperg, M; Lambert, D, 1993) |
| "In a 20-d, double-blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria." | 5.07 | A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria. ( Andri, G; Andri, L; Betteli, C; Givanni, S; Lombardi, C; Mezzelani, P; Senna, GE, 1993) |
| "The objective of these three double-blind multi-centre studies was to determine whether terfenadine 120 mg once daily has similar efficacy and tolerability as the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 5.06 | Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily. ( , 1989) |
| "The objective of this double-blind study, which is part of a multicenter study, was to determine whether terfenadine (120 mg once daily) has similar efficacy and tolerability to the standard dosage of 60 mg twice daily in the treatment of chronic urticaria." | 5.06 | Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria. ( Köhler, ME; Paul, E; Reinel, D; Ulrich, R, 1989) |
| "Forty patients with chronic urticaria were treated with terfenadine or astemizole in a randomized double-blind study." | 5.06 | Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients. ( Bödeker, RH; Paul, E, 1989) |
| "Patients (n = 56) with a diagnosis of chronic idiopathic urticaria were assessed in a fully randomized, double-blind, crossover study to investigate the efficacy of acrivastine at two doses (8 and 4 mg) versus 60 mg terfenadine and placebo administered three times daily." | 5.06 | A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. ( Blog, FB; den Boer, MS; Gibson, JR; Harvey, SG; Jansen, FC; Kuneman, JJ; Starink, TM; van Joost, T; Westerhof, W, 1989) |
| "The efficacy of terfenadine, a nonsedating H1 antihistamine, in the management of chronic idiopathic urticaria was compared with chlorpheniramine and placebo in a parallel multicenter trial." | 5.06 | Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. ( Bernstein, DI; Buckley, CE; Chu, T; Fox, RW; Grant, JA; Rocklin, RE; Schoenwetter, WF; Spector, SL; Stafford, CT; Stroh, JE, 1988) |
| "The use of the nonsedating antihistamine terfenadine (60 mg twice daily) in the treatment of chronic idiopathic urticaria and contact urticaria associated with atopic dermatitis was assessed." | 5.06 | Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. ( Hjorth, N, 1988) |
| "Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria." | 5.06 | Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. ( Cainelli, T; Mosca, M; Seidenari, S; Valsecchi, R, 1986) |
| "45 patients with chronic urticaria were randomized to double blind therapy with terfenadine an H1-antihistamine or ranitidine, an H2-antihistamine, or a combination of both drugs." | 5.06 | Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. ( Bödeker, RH; Paul, E, 1986) |
| "The effects of brompheniramine maleate (12 mg twice daily in sustained release form) and terfenadine (60 mg twice daily) on the symptoms and well-being of 16 adults with urticaria with or without dermographism were assessed by symptom questionnaire." | 5.06 | Terfenadine and brompheniramine maleate in urticaria and dermographism. ( Baker, R; Ormerod, AD; Watt, J; White, MI, 1986) |
| "Terfenadine, a new specific and peripherally acting antihistamine, was compared with clemastine and placebo in a prospective, randomized, double-blind, double-dummy, crossover study of the treatment of chronic urticaria." | 5.06 | Terfenadine in chronic urticaria: a comparison with clemastine and placebo. ( Fredriksson, T; Hersle, K; Hjorth, N; Mobacken, H; Persson, T; Salde, L; Salo, O; Schmidt, H; Thomsen, K, 1986) |
| "Results of a double-blind, randomized, placebo-controlled, parallel study in 37 patients indicate that terfenadine, 60 mg bid, is significantly more effective than placebo and as effective as hydroxyzine, 25 mg qid, in the treatment of chronic idiopathic urticaria without causing the somnolence that was associated with the use of hydroxyzine." | 5.06 | Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. ( Ball, R; Boggs, PB; Ellis, CN; Grossman, J; Gupta, AK; Shulan, D; Washburne, WF, 1989) |
| "40 patients suffering from chronic urticaria were randomly treated with either Terfenadine or Astemizole." | 5.05 | [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients]. ( Bödeker, RH; Paul, E, 1985) |
| "Terfenadine, a potent and non-sedative antihistamine, was shown to be effective in chronic idiopathic urticaria in a double-blind crossover placebo controlled trial." | 5.05 | Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study. ( Ferguson, J; Kenicer, KJ; MacDonald, KJ, 1985) |
| " In a double blind crossover study of twenty-four patients with chronic idiopathic urticaria, we have found terfenadine to be a non-sedative and highly effective drug." | 5.05 | Treatment of chronic idiopathic urticaria with terfenadine. ( Cerio, R; Lessof, MH, 1984) |
| "The second-generation H1-receptor antagonists terfenadine, astemizole, loratadine, and cetirizine are important first-line drugs for the relief of symptoms in patients with allergic rhinoconjunctivitis or chronic urticaria and may eventually supplant the potentially sedating first-generation H1-receptor antagonists in the treatment of these disorders." | 4.78 | Recent advances in H1-receptor antagonist treatment. ( Simons, FE, 1990) |
| "Urticaria is mainly caused by mast cell-derived histamine through the histamine H(1) receptor." | 3.78 | Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch. ( Fukuoka, M; Ikoma, A; Kabashima, K; Miyachi, Y; Tanizaki, H, 2012) |
| " We report a patient with urticaria due to ingestion of ebastine and fexofenadine." | 3.77 | Urticaria due to antihistamines. ( Laguna Martínez, JJ; Reaño Martos, M; Rojas Pérez-Ezquerra, P; Sánchez Morillas, L; Sanz, ML, 2011) |
| "A 40-year-old male medical student presented with urticarial vasculitis secondary to occupational formaldehyde exposure." | 3.74 | Formaldehyde-induced urticarial vasculitis. ( Marshman, G; Pellizzari, M, 2007) |
| "fexofenadine is clinically effective in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria for which it is a suitable option for first-line therapy." | 3.70 | Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. ( Jarvis, B; Simpson, K, 2000) |
| " The present study was aimed at testing the therapeutic effects and side effects of nimodipine therapy, a new dihydropyridine anti-calcium derivative for physical stimulus-induced urticaria, in comparison with a standard H1-antihistamine therapy." | 3.68 | Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria. ( Altomare, G; Bigardi, A; Finzi, AF; Fumagalli, M; Pigatto, PD, 1990) |
| "To investigate the mechanisms of non-immunologic contact urticaria (NICU), the effect of 120 mg of terfenadine (H1-antagonist) on contact reactions to methyl nicotinate, diethyl fumarate, benzoic acid, cinnamic acid, cinnamic aldehyde and dimethyl sulfoxide was studied in 20 subjects." | 3.67 | Terfenadine does not inhibit non-immunologic contact urticaria. ( Lahti, A, 1987) |
| "Treatment with the H1 receptor antagonist terfenadine increased significantly the dose of radiation required for weal and flare formation in 5 patients with idiopathic solar urticaria." | 3.67 | Treatment of solar urticaria with terfenadine. ( Diffey, BL; Farr, PM, 1988) |
| "Levocetirizine was more inhibitory than fexofenadine on wheal, flare and pruritus (p < 0." | 2.78 | The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers. ( Church, MK; Maurer, M; Schoepke, N, 2013) |
| "Fexofenadine (180 mg/d) was taken during the run-in period and subsequently throughout the study and follow-up as required." | 2.73 | Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. ( Borzova, E; Grattan, CE; Konstantinou, GN; Leslie, KS; Rutherford, A, 2008) |
| "To evaluate the efficacy and safety of once-daily dosing of fexofenadine hydrochloride, 180 mg, on CIU." | 2.71 | Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. ( Georges, G; Kaplan, AP; Liao, Y; Meeves, S; Spector, SL; Varghese, ST, 2005) |
| "Fexofenadine is a potent suppressor of the histamine-induced wheal and flare response in healthy Japanese volunteers." | 2.71 | Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers. ( Boyle, J; Hindmarch, I; Johnsen, S; Meadows, R; Ridout, F, 2005) |
| " Adverse events occurred in 20 cases (18." | 2.70 | Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria. ( Aunhachoke, K; Charuwichitratana, S; Gherunpong, N; Gritiyarangsan, P; Janjumratsang, P; Jiamton, S; Korkij, W; Krisadapong, J; Kullavanijaya, P; Kulthanan, K; Kuntiranont, M; Sitakalin, C, 2001) |
| "Fexofenadine 180 mg is a new antihistamine that is effective in the treatment of chronic urticaria and that has a profile of side effects similar to placebo." | 2.70 | [Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients]. ( Bircher, A; Degonda, M; Helbling, A; Pichler, WJ, 2002) |
| "Loratadine was the least potent inhibitor." | 2.69 | A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. ( Danielson, L; DeVos, C; Grant, JA; Rihoux, JP, 1999) |
| "Bradykinin (BK) is a vasoactive polypeptide formed by the action of enzymes known as kallikreins on inactive precursors called kininogens." | 2.68 | Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin. ( Archer, CB; Brooks, J; Burton, JL; Sansom, JE, 1996) |
| "3." | 2.68 | Actions of terfenadine and cimetidine on histamine wheal formation. ( Vere, DW, 1995) |
| " Marked sedation occurred in three of the first 10 subjects treated with topical doxepin, necessitating a reduction in dosage for the remaining six subjects." | 2.68 | The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin. ( Archer, CB; Kennedy, CT; Sabroe, RA, 1997) |
| " At the dosage used, cetirizine therapy appears to be no more effective than terfenadine." | 2.67 | A comparison of cetirizine and terfenadine in the management of solar urticaria. ( Bilsland, D; Ferguson, J, 1991) |
| "Treatment with hydroxyzine in patients with CU improved the clinical symptoms and modified the profile of HR; more histamine was recovered at 1 hour (p less than 0." | 2.67 | Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria. ( Bédard, PM; Brunet, C; Hébert, J, 1990) |
| "Terfenadine was significantly more effective than placebo at day 7 and endpoint (last valid visit)." | 2.67 | Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. ( Belaich, S; Bruttmann, G; DeGreef, H; Lachapelle, JM; Paul, E; Pedrali, P; Tennstedt, D, 1990) |
| " A combination of the two drugs both in "standard" and modified dosage resulted in the greatest reduction in the wheal and flare." | 2.66 | Effect of terfenadine and ranitidine on histamine and suxamethonium wheals. ( Bödeker, RH; Paul, E; Pfeffer, M, 1988) |
| "Guidelines for the treatment of urticaria issued by Polish and international expert bodies were analyzed, along with the SPCs." | 2.49 | [Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs]. ( Plichta, D; Spiewak, R, 2013) |
| " No major cytochrome P450 inhibition has been reported with desloratadine, fexofenadine and levocetirizine, and the bioavailability of desloratadine is minimally affected by drugs interfering with transporter molecules." | 2.44 | Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review. ( Devillier, P; Faisy, C; Roche, N, 2008) |
| "Total 100 patients of chronic idiopathic urticaria aged 18 years and above with exclusion and inclusion criteria were selected." | 1.56 | Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria. ( Akhter, F; Jahan, H; Nandi, AK, 2020) |
| " In cases of failure, treatment was switched to omalizumab at doses of < 300 mg/month with incremental dosage increases as necessary (monthly dose range, 150-600 mg/month)." | 1.51 | Real-life experience in the treatment of solar urticaria: retrospective cohort study. ( Enk, CD; Hodak, E; Lapidoth, M; Levi, A; Mazor, S; Snast, I; Uvaidov, V, 2019) |
| "The treatment with terfenadine was continued." | 1.35 | Solar urticaria successfully treated with intravenous immunoglobulins. ( Dubertret, L; Frémont, G; Jeanmougin, M; Maksimovic, L; Viguier, M, 2009) |
| " It is concluded that estimating in vivo receptor occupancy, which takes into account both the affinity of the drug for the receptor and its free plasma concentration, is a far better predictor for human pharmacodynamics and hence antihistamine potency, than considering in vitro affinity and plasmatic half-life only." | 1.33 | Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. ( Baltes, E; Benedetti, MS; Chatelain, P; Gillard, M, 2005) |
| " Fexofenadine given in the conventional dosage can prevent recurrences and represents a successful treatment measure when dealing with this peculiar form of solar urticaria." | 1.31 | Fixed solar urticaria to visible light successfully treated with fexofenadine. ( Bazex, J; Journé, F; Loche, E; Marguery, MC; Schwarze, HP, 2001) |
| "Terfenadine is a widely used antihistamine." | 1.29 | Torsade de pointes induced by terfenadine in a patient with long QT syndrome. ( Kim, SS; Koh, KK; Rim, MS; Yoon, J, 1994) |
| "Solar urticaria is a rare photodermatosis, but it is extremely incapacitating and therapy is usually ineffective." | 1.28 | [Treatment of solar urticaria: advantage of terfenadine]. ( Civatte, J; Jeanmougin, M; Manciet, JR; Moulin, JP, 1989) |
| "Under H1 treatment, the urticaria was florid and the ice cube test clearly positive." | 1.27 | Successful treatment of idiopathic cold urticaria with the association of H1 and H2 antagonists: a case report. ( Duc, J; Pécoud, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (26.45) | 18.7374 |
| 1990's | 33 (27.27) | 18.2507 |
| 2000's | 38 (31.40) | 29.6817 |
| 2010's | 16 (13.22) | 24.3611 |
| 2020's | 2 (1.65) | 2.80 |
| Authors | Studies |
|---|---|
| Jahan, H | 1 |
| Akhter, F | 1 |
| Nandi, AK | 1 |
| Hassan, K | 1 |
| Snast, I | 1 |
| Lapidoth, M | 1 |
| Uvaidov, V | 1 |
| Enk, CD | 2 |
| Mazor, S | 1 |
| Hodak, E | 1 |
| Levi, A | 2 |
| Hassoun, Y | 1 |
| Stevenson, MR | 1 |
| Bernstein, DI | 2 |
| Tanizaki, H | 3 |
| Nakahigashi, K | 1 |
| Miyachi, Y | 3 |
| Kabashima, K | 3 |
| Bulan, K | 1 |
| Aydogan, M | 1 |
| Siraneci, R | 1 |
| Aydogmus, CY | 1 |
| Kawada, T | 1 |
| Plichta, D | 1 |
| Spiewak, R | 1 |
| Guo, A | 1 |
| Zhu, W | 1 |
| Zhang, C | 1 |
| Wen, S | 1 |
| Chen, X | 2 |
| Chen, M | 1 |
| Zhang, J | 1 |
| Su, J | 1 |
| Chen, W | 1 |
| Zhao, Y | 1 |
| Yan, S | 1 |
| He, Y | 1 |
| Liu, Z | 1 |
| Zhou, H | 1 |
| Li, J | 1 |
| Yamamoto, Y | 1 |
| Nakamizo, S | 1 |
| Otsuka, A | 1 |
| Hirohata, A | 1 |
| Yamaoka, T | 1 |
| Hayashi, M | 1 |
| Murota, H | 1 |
| Tani, M | 1 |
| Katayama, I | 1 |
| Hama, N | 1 |
| Shimomura, Y | 1 |
| Arinami, H | 1 |
| Maruyama, R | 1 |
| Abe, R | 1 |
| Izumi, N | 1 |
| Mizuguchi, H | 1 |
| Umehara, H | 1 |
| Ogino, S | 1 |
| Fukui, H | 1 |
| Borzova, E | 1 |
| Rutherford, A | 1 |
| Konstantinou, GN | 1 |
| Leslie, KS | 1 |
| Grattan, CE | 1 |
| Maksimovic, L | 1 |
| Frémont, G | 1 |
| Jeanmougin, M | 2 |
| Dubertret, L | 1 |
| Viguier, M | 1 |
| Inomata, N | 1 |
| Tatewaki, S | 1 |
| Ikezawa, Z | 1 |
| dos Santos, RV | 1 |
| Magerl, M | 1 |
| Mlynek, A | 1 |
| Lima, HC | 1 |
| Shaikh, WA | 1 |
| Shaikh, SW | 1 |
| Sánchez Morillas, L | 1 |
| Rojas Pérez-Ezquerra, P | 1 |
| Reaño Martos, M | 1 |
| Sanz, ML | 1 |
| Laguna Martínez, JJ | 1 |
| Kamei, H | 1 |
| Isaji, A | 1 |
| Noda, Y | 1 |
| Ishikawa, K | 1 |
| Senzaki, K | 1 |
| Yamada, K | 1 |
| Sugiura, K | 1 |
| Tomita, Y | 1 |
| Nabeshima, T | 1 |
| Ikoma, A | 1 |
| Fukuoka, M | 1 |
| Church, MK | 2 |
| Maurer, M | 2 |
| Schoepke, N | 1 |
| Chowdhury, BA | 1 |
| Cassano, N | 1 |
| Filotico, R | 1 |
| D'Argento, V | 1 |
| Filieri, M | 1 |
| Coviello, C | 1 |
| Vena, G | 1 |
| Kawashima, M | 1 |
| Harada, S | 1 |
| Tango, T | 1 |
| Mekkes, JR | 1 |
| de Vries, HJ | 1 |
| Kammeyer, A | 1 |
| Duchateau, J | 1 |
| Heenen, M | 1 |
| Sternon, J | 1 |
| Handa, S | 1 |
| Dogra, S | 1 |
| Kumar, B | 1 |
| Roongapinun, S | 1 |
| Wajajamreon, S | 1 |
| Fooanant, S | 1 |
| Lennox, RD | 2 |
| Leahy, MJ | 2 |
| Purohit, A | 1 |
| N'Gom, AS | 1 |
| Deslandes, B | 1 |
| Pauli, G | 1 |
| Frossard, N | 1 |
| Shikiar, R | 2 |
| Harding, G | 2 |
| Leahy, M | 1 |
| Kaplan, AP | 2 |
| Spector, SL | 3 |
| Meeves, S | 2 |
| Liao, Y | 1 |
| Varghese, ST | 2 |
| Georges, G | 2 |
| Dhar, S | 1 |
| Boyle, J | 2 |
| Ridout, F | 1 |
| Meadows, R | 1 |
| Johnsen, S | 1 |
| Hindmarch, I | 1 |
| Gillard, M | 1 |
| Benedetti, MS | 1 |
| Chatelain, P | 1 |
| Baltes, E | 1 |
| Kłos, K | 2 |
| Kruszewski, J | 2 |
| Kruszewski, R | 1 |
| Sułek, K | 2 |
| Pellizzari, M | 1 |
| Marshman, G | 1 |
| Benhamou, AH | 1 |
| Vanini, G | 1 |
| Lantin, JP | 1 |
| Eigenmann, PA | 1 |
| Takahashi, H | 1 |
| Zhang, Y | 1 |
| Morita, E | 1 |
| Devillier, P | 1 |
| Roche, N | 1 |
| Faisy, C | 1 |
| De Vos, C | 1 |
| Mitchev, K | 1 |
| Pinelli, ME | 1 |
| Derde, MP | 1 |
| Boev, R | 1 |
| Warin, RP | 1 |
| Neumann, Y | 1 |
| Krause, LB | 1 |
| Shuster, S | 3 |
| Cerio, R | 1 |
| Lessof, MH | 1 |
| Koh, KK | 1 |
| Rim, MS | 1 |
| Yoon, J | 1 |
| Kim, SS | 1 |
| Androsov, VN | 1 |
| Belostotskaia, OI | 1 |
| Il'ina, NI | 1 |
| Goldsmith, P | 1 |
| Dowd, PM | 1 |
| Sharpe, GR | 1 |
| Masheter, HC | 1 |
| Lambert, D | 1 |
| Hantzperg, M | 1 |
| Danglas, P | 1 |
| Bloom, M | 2 |
| Andri, L | 1 |
| Senna, GE | 1 |
| Betteli, C | 1 |
| Givanni, S | 1 |
| Andri, G | 1 |
| Lombardi, C | 1 |
| Mezzelani, P | 1 |
| Bernhard, JD | 2 |
| Miyauchi, H | 1 |
| Horio, T | 1 |
| Sansom, JE | 1 |
| Brooks, J | 1 |
| Burton, JL | 1 |
| Archer, CB | 2 |
| Vere, DW | 1 |
| Kalis, B | 1 |
| Leong, KP | 1 |
| Chng, HH | 1 |
| Sabroe, RA | 1 |
| Kennedy, CT | 1 |
| Paul, E | 8 |
| Markham, A | 1 |
| Wagstaff, AJ | 1 |
| Rihoux, JP | 4 |
| Donnelly, F | 1 |
| Burtin, B | 1 |
| Grant, JA | 3 |
| Danielson, L | 1 |
| DeVos, C | 2 |
| Finn, AF | 2 |
| Fretwell, R | 1 |
| Qu, R | 1 |
| Long, J | 1 |
| Simpson, K | 1 |
| Jarvis, B | 1 |
| Nelson, HS | 1 |
| Reynolds, R | 1 |
| Mason, J | 1 |
| Reimers, A | 1 |
| Hari, Y | 1 |
| Müller, U | 1 |
| Thompson, AK | 1 |
| Schoenwetter, WF | 2 |
| Schwarze, HP | 1 |
| Marguery, MC | 1 |
| Journé, F | 1 |
| Loche, E | 1 |
| Bazex, J | 1 |
| Nettis, E | 1 |
| Dambra, P | 1 |
| D'Oronzio, L | 1 |
| Loria, MP | 1 |
| Ferrannini, A | 1 |
| Tursi, A | 1 |
| Amichai, B | 1 |
| Grunwald, MH | 1 |
| Brenner, L | 1 |
| Kulthanan, K | 1 |
| Gritiyarangsan, P | 1 |
| Sitakalin, C | 1 |
| Charuwichitratana, S | 1 |
| Korkij, W | 1 |
| Aunhachoke, K | 1 |
| Janjumratsang, P | 1 |
| Jiamton, S | 1 |
| Kuntiranont, M | 1 |
| Krisadapong, J | 1 |
| Gherunpong, N | 1 |
| Kullavanijaya, P | 1 |
| Riethuisen, JM | 1 |
| Moulaert, B | 1 |
| Degonda, M | 1 |
| Pichler, WJ | 1 |
| Bircher, A | 1 |
| Helbling, A | 1 |
| Abu Shareeah, AM | 1 |
| Duffull, SB | 1 |
| Begg, EJ | 1 |
| Nichols, AW | 1 |
| Soter, NA | 1 |
| Fisher, DA | 1 |
| Bilsland, D | 1 |
| Ferguson, J | 2 |
| Brunet, C | 1 |
| Bédard, PM | 1 |
| Hébert, J | 1 |
| Miller, SD | 1 |
| Pritchard, D | 1 |
| Crowley, JP | 1 |
| Belaich, S | 1 |
| Bruttmann, G | 1 |
| DeGreef, H | 1 |
| Lachapelle, JM | 1 |
| Pedrali, P | 1 |
| Tennstedt, D | 1 |
| Pigatto, PD | 1 |
| Fumagalli, M | 1 |
| Bigardi, A | 1 |
| Altomare, G | 1 |
| Finzi, AF | 1 |
| Simons, FE | 2 |
| McMillan, JL | 1 |
| Simons, KJ | 1 |
| Kietzmann, H | 1 |
| Macher, E | 1 |
| Ghys, L | 1 |
| Bödeker, RH | 5 |
| Manciet, JR | 1 |
| Moulin, JP | 1 |
| Civatte, J | 1 |
| van Joost, T | 1 |
| Blog, FB | 1 |
| Westerhof, W | 1 |
| Jansen, FC | 1 |
| Starink, TM | 1 |
| den Boer, MS | 1 |
| Kuneman, JJ | 1 |
| Harvey, SG | 1 |
| Gibson, JR | 2 |
| Marks, P | 1 |
| Cox, NH | 1 |
| Higgins, EM | 1 |
| Forr, PM | 1 |
| Reinel, D | 1 |
| Ulrich, R | 1 |
| Köhler, ME | 1 |
| Boggs, PB | 1 |
| Ellis, CN | 1 |
| Grossman, J | 1 |
| Washburne, WF | 1 |
| Gupta, AK | 1 |
| Ball, R | 1 |
| Shulan, D | 1 |
| Duc, J | 1 |
| Pécoud, A | 1 |
| Fredriksson, T | 1 |
| Hersle, K | 1 |
| Hjorth, N | 2 |
| Mobacken, H | 1 |
| Persson, T | 1 |
| Salde, L | 1 |
| Salo, O | 1 |
| Schmidt, H | 1 |
| Thomsen, K | 1 |
| Ormerod, AD | 1 |
| Baker, R | 1 |
| Watt, J | 1 |
| White, MI | 1 |
| Pfeffer, M | 2 |
| Lahti, A | 1 |
| Cainelli, T | 1 |
| Seidenari, S | 1 |
| Valsecchi, R | 1 |
| Mosca, M | 1 |
| Diffey, BL | 1 |
| Farr, PM | 1 |
| Salisbury, J | 1 |
| Bor, S | 1 |
| Blair, C | 1 |
| Pechadre, JC | 1 |
| Vernay, D | 1 |
| Trolese, JF | 1 |
| Dupont, P | 1 |
| Buckley, CE | 1 |
| Chu, T | 1 |
| Fox, RW | 1 |
| Rocklin, RE | 1 |
| Stafford, CT | 1 |
| Stroh, JE | 1 |
| Rajatanavin, N | 1 |
| Lembo, G | 1 |
| Raulo, U | 1 |
| Cantelli, V | 1 |
| Patruno, C | 1 |
| Eichelberg, D | 1 |
| Shall, L | 1 |
| Newcombe, RG | 1 |
| Marks, R | 1 |
| MacDonald, KJ | 1 |
| Kenicer, KJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Observational Study of the Prevalence of Antihistamine Responsive Gastrointestinal Symptoms in Patients Diagnosed With Irritable Bowel Syndrome With Diarrhea[NCT04612803] | 100 participants (Anticipated) | Observational | 2020-11-15 | Not yet recruiting | |||
| Comparison of Efficacy and Consistency of Action of Levocetirizine 5 mg Once Daily With Fexofenadine 60 mg Twice Daily in the Histamine Induced Wheal, Flare and Itch Response[NCT01586091] | Phase 4 | 18 participants (Actual) | Interventional | 2011-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Flaire diameter was measured with a transparent ruler as the mean of the largest diameter and the diameter at right angles to this. (NCT01586091)
Timeframe: 24 hours per treatment
| Intervention | mm (Mean) |
|---|---|
| Placebo | 69.4 |
| Levocetirizin | 20.4 |
| Fexofenadine | 39.9 |
"We measured drug concentrations and various aspects of skin provocation testing such as itch intensity and wheal size. Measurements made at each time point were as followed: Pruritus was assessed every 30 s for 10 min after SPT using a visual analogue scale (VAS) score with a 0 and 100 at the two ex- tremes of an unmarked 100 mm line with higher values indicating greater puritus. The mean VAS for each 10 min was calculated and used as a primary end Point." (NCT01586091)
Timeframe: up to 10 minutes after skin prick test performed 24 hours after drug administration
| Intervention | mm (Mean) |
|---|---|
| Levocetirizin | 11.5 |
| Fexofenadine | 25.4 |
| Placebo | 46.0 |
Wheal volume was measured by a non-contact three dimensional measurement system (PRIMOS contact, GFM Messtechnik GmbH, Teltow, Germany). (NCT01586091)
Timeframe: 24 hours per treatment
| Intervention | cm3 (Mean) |
|---|---|
| Placebo | 174.6 |
| Levocetirizin | 35.2 |
| Fexofenadine | 106.3 |
12 reviews available for terfenadine and Hives
| Article | Year |
|---|---|
[Pharmacotherapy of urticaria--an analysis of the discrepancies between guidelines of expert bodies, registration documents and evidence for the effectiveness of drugs].
Topics: Administration, Oral; Administration, Topical; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Glu | 2013 |
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
Topics: Anti-Allergic Agents; Cetirizine; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratad | 2012 |
Review of fexofenadine in the treatment of chronic idiopathic urticaria.
Topics: Anti-Allergic Agents; Asia; Chronic Disease; Humans; North America; Terfenadine; Urticaria | 2002 |
[H1 histamine antagonists].
Topics: Acetates; Anti-Allergic Agents; Cetirizine; Chemistry, Pharmaceutical; Histamine H1 Antagonists; Hum | 2003 |
Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Topics: Cetirizine; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Rhinitis, | 2008 |
The new H1 antihistamines. Treatment of urticaria and other clinical problems.
Topics: Astemizole; Cetirizine; Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Loratadine; Terfenadin | 1993 |
Terfenadine. The first nonsedating antihistamine.
Topics: Adult; Asthma; Child; Drug Interactions; Electroencephalography; Humans; Rhinitis; Skin Tests; Terfe | 1993 |
Coincident cold urticaria in a married couple: case report and a literature review.
Topics: Adult; Anti-Allergic Agents; Cold Temperature; Female; Humans; Male; Marriage; Middle Aged; Remissio | 1997 |
Fexofenadine.
Topics: Animals; Histamine Antagonists; Humans; Rhinitis, Allergic, Seasonal; Terfenadine; Urticaria | 1998 |
Fexofenadine hydrochloride--a new anti-histaminic drug.
Topics: Chronic Disease; Clinical Trials as Topic; Drug Interactions; Histamine H1 Antagonists; Humans; Pati | 2001 |
Exercise-induced anaphylaxis and urticaria.
Topics: Anaphylaxis; Astemizole; Clemastine; Exercise; Humans; Terfenadine; Urticaria | 1992 |
Recent advances in H1-receptor antagonist treatment.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Histamine H1 Antagonis | 1990 |
64 trials available for terfenadine and Hives
| Article | Year |
|---|---|
Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticaria and histamine-induced skin responses in Japanese populations.
Topics: Adult; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Histamine; Histamine H1 Ant | 2013 |
The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial.
Topics: Acetates; Allergens; Animals; Asthma; Chi-Square Distribution; Child; Cyclopropanes; Dose-Response R | 2013 |
Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
Topics: Adult; Asian People; Benzimidazoles; China; Female; Genotyping Techniques; Histamine H1 Antagonists, | 2015 |
Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
Topics: Adult; Anti-Allergic Agents; Chronic Disease; Cross-Over Studies; Dibenzoxepins; Female; Histamine H | 2015 |
Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study.
Topics: Adult; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Male; Pilot Projects; Prospective | 2008 |
Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
Topics: Adult; Allergens; Animals; Dermatophagoides pteronyssinus; Dibenzazepines; Double-Blind Method; Fema | 2009 |
Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
Topics: Adolescent; Dibenzoxepins; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Olop | 2012 |
The inhibition by levocetirizine and fexofenadine of the histamine-induced wheal and flare response in healthy Caucasian and Japanese volunteers.
Topics: Adult; Asian People; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind | 2013 |
Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Seda | 2004 |
Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
Topics: Adolescent; Adult; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; M | 2004 |
Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
Topics: Chronic Disease; Dermatology; Dose-Response Relationship, Drug; Double-Blind Method; Histamine H1 An | 2004 |
Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
Topics: Adolescent; Adult; Cetirizine; Cross-Over Studies; Female; Histamine; Histamine H1 Antagonists; Huma | 2004 |
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Terfenadine; Urticari | 2005 |
Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Topics: Adult; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Japan; Loratadine; Male; | 2005 |
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Drug Administration Schedule; Histamin | 2006 |
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Histamine; Histamine H1 Antagonists, N | 2006 |
The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria.
Topics: Adolescent; Chronic Disease; Double-Blind Method; Efficiency; Female; Histamine H1 Antagonists, Non- | 2007 |
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: a double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
Topics: Adult; Cetirizine; Cross-Over Studies; Dibenzoxepins; Dose-Response Relationship, Drug; Double-Blind | 2008 |
[Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine].
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Female; Hist | 1984 |
The effect of terfenadine on dermographic wealing.
Topics: Adolescent; Adult; Benzhydryl Compounds; Clinical Trials as Topic; Dose-Response Relationship, Drug; | 1984 |
Treatment of chronic idiopathic urticaria with terfenadine.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Double-Blind Method; Humans; Placebos; Random Alloca | 1984 |
[The efficacy of the Zirtek (cetirizine) preparation in chronic recurrent urticaria and seasonal allergic rhinitis].
Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Mid | 1994 |
In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared with H1 antagonists alone.
Topics: Adolescent; Adult; Aged; Cetirizine; Double-Blind Method; Female; Humans; Male; Middle Aged; Ranitid | 1993 |
[Double-blind comparative study of terfenadine and cetirizine in chronic idiopathic urticaria].
Topics: Adolescent; Adult; Cetirizine; Child; Chronic Disease; Double-Blind Method; Female; Humans; Male; Mi | 1993 |
A comparison of the efficacy of cetirizine and terfenadine. A double-blind, controlled study of chronic idiopathic urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Double-Blind Method; Humans; Terfenadine; Urticaria | 1993 |
Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Topics: Administration, Oral; Bradykinin; Cimetidine; Codeine; Double-Blind Method; Doxepin; Histamine; Hist | 1996 |
Actions of terfenadine and cimetidine on histamine wheal formation.
Topics: Adult; Cimetidine; Drug Combinations; Female; Histamine; Histamine H1 Antagonists; Histamine H2 Anta | 1995 |
Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
Topics: Adult; Anti-Allergic Agents; Butyrophenones; Chronic Disease; Double-Blind Method; Histamine H1 Anta | 1996 |
The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Topics: Administration, Topical; Adult; Antipruritics; Dermatitis, Atopic; Dinoprostone; Double-Blind Method | 1997 |
A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Topics: Adult; Butyrophenones; Cetirizine; Cross-Over Studies; Dibenzazepines; Double-Blind Method; Histamin | 1999 |
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonis | 1999 |
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chronic Disease; Disorders of Excessive Somnol | 2000 |
Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Angioedema; Anti-Allergic Agents; Bee Venoms; Double-Blind Method; Drug Therapy, | 2000 |
Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male; Middle Age | 2000 |
Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
Topics: Acetates; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Ant | 2001 |
Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Histamine H1 Antagonists; Human | 2001 |
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Topics: Adult; Benzimidazoles; Butyrophenones; Cetirizine; Cross-Over Studies; Double-Blind Method; Histamin | 2002 |
[Chronic idiopathic urticaria: effectiveness of fexofenadine. A double-blind, placebo controlled study with 21 patients].
Topics: Adult; Aged; Anti-Allergic Agents; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middl | 2002 |
Comparative efficacy of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adult; Chronic Disease; Cyproheptadine; Female; Histamine Antagonists; Humans; Loratadine; Male; Pru | 1992 |
Terfenadine ineffective in the prophylaxis of exercise-induced pruritus.
Topics: Adult; Exercise; Humans; Male; Pruritus; Running; Terfenadine; Urticaria | 1992 |
A comparison of cetirizine and terfenadine in the management of solar urticaria.
Topics: Adult; Aged; Cetirizine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; | 1991 |
Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; | 1990 |
Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Cyprohepta | 1990 |
A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
Topics: Adult; Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Chlorpheniramine; Cyproheptadin | 1990 |
Comparison of cetirizine and terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Benzhydryl Compounds; Cetirizine; Chronic Disease; Double-Blind Method; Histamine H1 Antagonists; Hu | 1990 |
Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Double- | 1989 |
A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1989 |
Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
Topics: Adult; Benzhydryl Compounds; Clinical Trials as Topic; Double-Blind Method; Female; Histamine H1 Ant | 1989 |
Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
Topics: Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Histamine | 1989 |
Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
Topics: Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Fem | 1989 |
Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Histamine H1 Antagoni | 1989 |
[Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Double- | 1985 |
Terfenadine in chronic urticaria: a comparison with clemastine and placebo.
Topics: Adult; Aged; Benzhydryl Compounds; Clemastine; Clinical Trials as Topic; Double-Blind Method; Female | 1986 |
Terfenadine and brompheniramine maleate in urticaria and dermographism.
Topics: Adult; Benzhydryl Compounds; Brompheniramine; Clinical Trials as Topic; Double-Blind Method; Histami | 1986 |
Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients.
Topics: Adult; Aged; Benzhydryl Compounds; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; | 1986 |
[Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies].
Topics: Benzhydryl Compounds; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Ranitidine; Terfe | 1987 |
Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
Topics: Adolescent; Adult; Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Double-Blind M | 1986 |
A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Bli | 1987 |
Comparison of the central and peripheral effects of cetirizine and terfenadine.
Topics: Adult; Benzhydryl Compounds; Cetirizine; Electroencephalography; Histamine; Histamine H1 Antagonists | 1988 |
Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clemastine; Dermatitis, Atopic; Doub | 1988 |
Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria.
Topics: Adolescent; Adult; Benzhydryl Compounds; Chlorpheniramine; Chronic Disease; Clinical Trials as Topic | 1988 |
Effect of terfenadine and ranitidine on histamine and suxamethonium wheals.
Topics: Adolescent; Adult; Benzhydryl Compounds; Double-Blind Method; Drug Therapy, Combination; Female; His | 1988 |
Assessment of the duration of action of terfenadine on histamine induced weals.
Topics: Adult; Benzhydryl Compounds; Double-Blind Method; Female; Histamine; Humans; Male; Middle Aged; Rand | 1988 |
Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double-blind study.
Topics: Adult; Aged; Benzhydryl Compounds; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; F | 1985 |
45 other studies available for terfenadine and Hives
| Article | Year |
|---|---|
Efficacy of Fexofenadine in the Treatment of Chronic Idiopathic Urticaria.
Topics: Adolescent; Bangladesh; Chronic Disease; Chronic Urticaria; Double-Blind Method; Humans; Terfenadine | 2020 |
Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection.
Topics: Angioedema; Anti-Allergic Agents; Betacoronavirus; Chlorpheniramine; Coronavirus Infections; COVID-1 | 2020 |
Real-life experience in the treatment of solar urticaria: retrospective cohort study.
Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cohort Studies; Cyclopro | 2019 |
Idiopathic postprandial diarrhea responsive to antihistamines.
Topics: Adult; Angioedema; Cetirizine; Diarrhea; Famotidine; Female; Food Hypersensitivity; Histamine Antago | 2019 |
The effect of antihistamines on behavioral activity by actigraphy.
Topics: Dibenzoxepins; Female; Histamine H1 Antagonists; Humans; Male; Promethazine; Psychomotor Performance | 2014 |
Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.
Topics: Acetates; Adolescent; Adult; Cetirizine; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combi | 2015 |
Unique case of postural cholinergic urticaria induced by a standing position.
Topics: Acetylcholine; Adolescent; Diphenhydramine; Humans; Male; Posture; Terfenadine; Urticaria | 2016 |
Localized heat urticaria: Positive reaction of preheated autologous serum skin test.
Topics: Anaphylaxis; Chlorpheniramine; Desensitization, Immunologic; Drug Therapy, Combination; Histamine H1 | 2016 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniram | 2008 |
Solar urticaria successfully treated with intravenous immunoglobulins.
Topics: Adult; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulins, Intravenous; Immunologic Fac | 2009 |
Multiple H1-antihistamine-induced urticaria.
Topics: Administration, Oral; Adult; Drug Eruptions; Female; Histamine; Histamine H1 Antagonists; Humans; Im | 2009 |
Allergies in India: a study on medication compliance.
Topics: Adolescent; Adult; Anti-Allergic Agents; Asthma; Bronchodilator Agents; Budesonide; Child; Ethanolam | 2009 |
Urticaria due to antihistamines.
Topics: Administration, Oral; Butyrophenones; Diagnosis, Differential; Drug Hypersensitivity; Female; Histam | 2011 |
Effects of bepotastine and fexofenadine on histamine-induced flare, wheal and itch.
Topics: Adult; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Piperidines; Pruritu | 2012 |
Chronic urticaria and angioedema.
Topics: Angioedema; Chronic Disease; Histamine H1 Antagonists; Humans; Terfenadine; Urticaria | 2002 |
In vivo anti-inflammatory effects of fexofenadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Biopsy, Needle; Case-Control Studies; Chronic Disease; Culture Techniques; E-Sele | 2002 |
Solar urticaria induced by infrared radiation.
Topics: Female; Histamine H1 Antagonists; Humans; Infrared Rays; Middle Aged; PUVA Therapy; Terfenadine; Urt | 2003 |
Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Clinical Trials, Phase III as Topic; Data Interpret | 2005 |
Assessing the therapeutic benefits of antihistamines for the treatment of chronic idiopathic urticaria--a requirement for well-designed comparative clinical studies.
Topics: Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Terfenadine; Treatment Outcome; Urticari | 2005 |
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
Topics: Animals; Cetirizine; CHO Cells; Cricetinae; Cricetulus; Histamine H1 Antagonists; Humans; Loratadine | 2005 |
Formaldehyde-induced urticarial vasculitis.
Topics: Adult; Drug Therapy, Combination; Formaldehyde; Glucocorticoids; Histamine H1 Antagonists, Non-Sedat | 2007 |
Antihistamine and sodium cromoglycate medication for food cold water exercise-induced anaphylaxis.
Topics: Adolescent; Anaphylaxis; Anti-Asthmatic Agents; Cold Temperature; Cromolyn Sodium; Drug Therapy, Com | 2007 |
Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.
Topics: Activities of Daily Living; Administration, Oral; Adult; Aged; Aged, 80 and over; Cetirizine; Child; | 2008 |
The effect of large doses of H1 antagonists in urticaria.
Topics: Adolescent; Adult; Benzhydryl Compounds; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged | 1984 |
Torsade de pointes induced by terfenadine in a patient with long QT syndrome.
Topics: Adult; Electrocardiography; Female; Humans; Long QT Syndrome; Terfenadine; Torsades de Pointes; Urti | 1994 |
Treatment of solar urticaria with terfenadine.
Topics: Astemizole; Humans; Sunlight; Terfenadine; Urticaria | 1993 |
Detection of action, inhibition and augmentation spectra in solar urticaria.
Topics: Anaphylaxis; Anti-Allergic Agents; Betamethasone; Cyclizine; Erythema; Female; Glucocorticoids; Hist | 1995 |
[Further development of terfenadine].
Topics: Clinical Trials as Topic; Histamine Antagonists; Histamine H1 Antagonists; Humans; Hypersensitivity, | 1997 |
The clinical efficacy of H1 antagonists in urticaria and rhinitis.
Topics: Anti-Allergic Agents; Cetirizine; Histamine H1 Antagonists; Humans; Loratadine; Mathematical Computi | 1998 |
Fexofenadine: new preparation. Terfenadine, without cardiotoxicity.
Topics: Cetirizine; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Histamine Antagonists; Human | 1999 |
Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Topics: Administration, Oral; Adolescent; Adult; Anti-Allergic Agents; Chronic Disease; Dose-Response Relati | 2000 |
Fixed solar urticaria to visible light successfully treated with fexofenadine.
Topics: Anti-Allergic Agents; Female; Humans; Middle Aged; Sunlight; Terfenadine; Ultraviolet Rays; Urticari | 2001 |
Treatment of urticaria and angioedema: low-sedating H1-type antihistamines.
Topics: Angioedema; Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Cyproheptadine; Histamine | 1991 |
A syndrome of acne vulgaris and subclinical dermographic urticaria.
Topics: Acne Vulgaris; Adolescent; Adult; Benzhydryl Compounds; Female; Histamine H1 Antagonists; Humans; Ma | 1991 |
Blood histamine levels following graded cold challenge in atypical acquired cold urticaria.
Topics: Adult; Cold Temperature; Female; Histamine; Humans; Terfenadine; Time Factors; Urticaria | 1992 |
Nimodipine versus terfenadine in the treatment of physical stimulus-induced urticaria.
Topics: Benzhydryl Compounds; Histamine H1 Antagonists; Humans; Nimodipine; Terfenadine; Urticaria | 1990 |
[Treatment of solar urticaria: advantage of terfenadine].
Topics: Adult; Benzhydryl Compounds; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Photosensi | 1989 |
Terfenadine inhibits itch and wheal, but not abnormal erythema, in physical urticarias.
Topics: Adult; Benzhydryl Compounds; Erythema; Female; Histamine H1 Antagonists; Humans; Middle Aged; Prurit | 1989 |
Successful treatment of idiopathic cold urticaria with the association of H1 and H2 antagonists: a case report.
Topics: Adult; Benzhydryl Compounds; Cimetidine; Cold Temperature; Drug Therapy, Combination; Histamine H1 A | 1986 |
Terfenadine does not inhibit non-immunologic contact urticaria.
Topics: Benzhydryl Compounds; Histamine H1 Antagonists; Humans; Terfenadine; Ultrasonography; Urticaria | 1987 |
Treatment of solar urticaria with terfenadine.
Topics: Adult; Benzhydryl Compounds; Erythema; Female; Histamine H1 Antagonists; Humans; Male; Sunlight; Ter | 1988 |
Antihistamines in the treatment of urticarial disorders.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; | 1988 |
Solar urticaria: treatment with terfenadine.
Topics: Adult; Benzhydryl Compounds; Female; Humans; Sunlight; Terfenadine; Urticaria | 1988 |
[Dermatographic urticaria: evaluation of the therapeutic efficacy of drugs using a dermatographic tester].
Topics: Adolescent; Adult; Benzhydryl Compounds; Chronic Disease; Cinnarizine; Female; Humans; Hydroxyzine; | 1987 |
[Desensitization ("hardening") in heat urticaria].
Topics: Benzhydryl Compounds; Combined Modality Therapy; Female; Hot Temperature; Humans; Middle Aged; Skin | 1988 |